Academia’s postdoc system is teetering, imperiling efforts to diversify life sciences
For decades, the low pay and demanding hours were rewarded in the end. But for many, a postdoc is now a dead end.
Read The StoryPutting the latest life science research under the microscope: Our latest and most-read topics range from breast cancer to sickle cell anemia, Ehlers-Danlos syndrome to gene editing, HPV vaccines to obesity. These are the medical discoveries that can drive corporate strategy, money and market share in the life sciences industry.
For decades, the low pay and demanding hours were rewarded in the end. But for many, a postdoc is now a dead end.
Read The Story
advertisement